Genetic Test Reform Puts Fairness Back on the Life Insurance Agenda

At present, life insurers can consider a person’s medical and family history when assessing individually underwritten policies, although industry restrictions have limited how genetic test results are used. A statutory ban would go further by giving consumers stronger protection and clearer rights. The policy objective is straightforward: people should not be discouraged from taking medically useful genetic tests because they fear being priced out of life, disability or trauma cover later.

For corporate settings, the immediate impact may be uneven. Many group life insurance arrangements include automatic acceptance limits, meaning employees can receive a base level of cover without detailed medical underwriting. However, underwriting can still become relevant when senior staff, high-income employees, partners or directors seek higher cover levels, tailored executive benefits or business-owned protection.

This is where the reform matters most for SMEs and larger private companies. Key person, buy-sell and partnership insurance often require more detailed assessment because the sums insured can be substantial and the financial exposure is specific to the business. If genetic test information is removed from the underwriting equation, businesses may find conversations about protection easier, particularly where a founder or senior employee has previously hesitated to investigate cover.

That does not mean underwriting will disappear. Insurers are still expected to assess age, occupation, lifestyle, medical history, financial justification and policy purpose. Premiums and availability will continue to depend on the product, benefit amount and insurer appetite. Employers should therefore avoid assuming that reform will automatically make all cover cheaper or simpler.

The practical takeaway is to use the reform as a prompt for review. Businesses should check whether current employee benefits remain competitive, whether automatic acceptance limits suit their workforce, and whether ownership structures for business-owned policies still align with succession plans. For companies reliant on a small number of revenue-critical people, estimating appropriate levels of key person cover remains essential before seeking terms.

More broadly, the proposed ban reflects a market shift towards clearer, fairer and more consumer-centred life insurance. Employers that act early can turn that shift into a stronger risk management framework and a more reassuring benefits message for staff.